|
Home | Your Profile | Search | About Us | Disclaimer | Pricing | Participating on CanBiotech |
|
|
| |
Home | |
|
Services Showcase | |
|
Directory | |
|
News | |
|
Community | |
|
Career | |
| Go Back | |||
|
Antibe Therapeutics Job Posting: Chief Development Officer Boyden Global Executive Search 10/04/2007 19:08
Title: Chief Development Officer Reports To: CEO/Board of Directors Key Accountabilities: • Prepare development strategy; Location: Toronto, Canada
Antibe Therapeutics - www.antibe-therapeutics.com - is a privately held, early stage, global drug development company with offices in Canada and affiliate laboratories in the USA, United Kingdom, Italy and Brazil. The Company's pipeline consists of drugs targeting serious chronic diseases, including inflammatory bowel disease, erectile dysfunction, irritable bowel syndrome, pulmonary hypertension and various complications of diabetes. Antibe's unique drug development platform involves the assimilation of small vasoactive /immunomodulatory components to existing drugs to generate new chemical entities that are significantly improved over the parent molecules and/or serve unmet medical needs.
The Position: Combining knowledge of science, regulatory environments, clinical testing and business, the future incumbent will work with key stakeholders to ensure the optimum development planning and execution of Antibe’s drugs at different stages of the development process in various global jurisdictions. This leadership role supports Antibe’s business strategy and aligns all licensing, marketing and regulatory initiatives. This role requires the future leader to drive business results by planning and managing multiple projects run by teams of world class scientists and consultants (and stakeholders) located and working virtually, at various sites. This role requires entrepreneurial leadership, fierce intelligence, resourcefulness, creativity, and tenacity to manage both internal and external stakeholders across geographical jurisdictions and to deal with highly sensitive regulatory and cultural imperatives. The Chief Development Officer will work closely with the President/CEO and Board of Directors to guide development, and will provide internal expertise to The Company for all development and business development matters. All of this must be done while remaining effective within a de-centralized “start-up” business model. Responsibilities and Objectives of the Position Leadership: • Defining and managing project critical path activities and timelines; Stakeholder Engagement: • Developing appropriate network to ensure development support for commercial activities, e.g.: • Interacting with regulatory agencies, contract agencies and collaborators, as needed to achieve development goals; • Representing the drug development group externally in scientific presentations, conferences and industry groups.
The successful candidate will be passionately dedicated to the process of drug discovery and development, driven by team success and respectful of the “good-science” culture of the organization. The future incumbent must understand that this is a “start-up” fast-growth organization, so resourcefulness will be necessary. Previous experience with well established enterprises may serve as a foundation of knowledge and experience for this fast paced role, however, the future incumbent must have an appetite for creating a new drug development company. He/she will have the following qualifications, experience, skills and personal profile. Qualifications: • Ph.D. in a scientific discipline is preferred with 10 years' experience in global drug development in a biotech/pharmaceutical industry; and • Clear understanding of the overall drug development process from pre-clinical to NDA/BLA submission and market; Skills and Competencies: • Leadership: Able to lead and influence peers, superiors, and subordinates. Possesses excellent team-building skills and judgment in selection of key talent. Personal Attributes: • Fosters excellent relationships and credibility internally and externally and is able to effectively influence others in new and existing environments;
Excellent total compensation including strong base salary/bonus and highly rewarding stock option component reflecting this unique opportunity. Send Resumes to: Patrick Kielty |
BIO OUTSOURCING ASIA Volume 3 Issue 1 May 2010; Japan-An Evolving Opportunity CanBiotech 31 May 2010 NEW: CanBiotech Research Store CanBiotech 11 May 2010 Enabling Open Innovation in the Life Sciences BioEndeavor Network 27 Apr 2010 10th Edition: Clinical Trials in Canada Insight Information 23 Mar 2010 Bio Outsourcing Asia Volume 2 Issue 4: In Review, Spotlight on Canadian Companies in Asia CanBiotech 17 Mar 2010 65 NEW US VENTURE CAPITAL FIRMS ADDED TO OUR GLOBAL BIOPHARMACEUTICAL ONLINE VENTURE CAPITAL DIRECTORY; CURRENTLY INVESTING IN THE LIFE SCIENCES CanBiotech 10 Feb 2010 7th Annual Biomanufacturing Survey: Participation Request BioPlan Associates, Inc. 21 Dec 2009 Bio Outsourcing Asia Volume 2 Issue 3: DuBiotech: Dubai's Life Sciences Hub at the Crossroads of Asia, Europe and Africa CanBiotech 11 Nov 2009 Bio Outsourcing Asia: Call for Expert Writers; Case Studies CanBiotech 6 Oct 2009 Bio Outsourcing Asia Volume 2 Issue 2: Biopolis-Singapore's R&D Hub CanBiotech 31 Jul 2009 Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory Approval, and Access to Patients Drug Information Association 29 Jul 2009 DIA’S 7TH CANADIAN ANNUAL MEETING: Time to Act Drug Information Association 29 Jul 2009 Join our Outsourcing Showcase and Receive a Complementary Profile in our Upcoming Issue of Bio Outsourcing Asia CanBiotech 10 Jun 2009 Bio Outsourcing Asia Volume 2 Issue 1: Emerging Opportunities in India-A Profile of Mumbai CanBiotech 15 May 2009 Watch for the Release of our Bio Outsourcing Asia issue on Mumbai CanBiotech 20 Apr 2009 Watch for updates to our Canadian and Regional Directories CanBiotech 20 Apr 2009 Visit our New Taiwan BioChannel CanBiotech 20 Apr 2009 Bio Outsourcing Asia Issue 4: Malaysia-An Emerging Biotechnology Hub CanBiotech 11 Feb 2009 Watch for the Launch of our Taiwan Asset Map Including: Analysis of the Taiwan Biotechnology Sector, Two Asset Maps, and the Taiwan Directory and Company Pipeline Analysis CanBiotech 27 Oct 2008 Bio Outsourcing Asia Issue 3: Opportunities and Challenges in China; Spotlight on Taiwan CanBiotech 14 Oct 2008 Bio Outsourcing Asia Issue 2: Opportunities and Challenges in India CanBiotech 12 May 2008 Upcoming April Issue of Bio Outsourcing Asia CanBiotech 26 Mar 2008 New Reports on CanBiotech CanBiotech 26 Mar 2008 Advances in Biopharmaceutical Technology in India BioPlan Associates, Inc. 29 Jan 2008 Inaugural Issue Bio Outsourcing Asia: December 2007 CanBiotech 25 Dec 2007 Watch for the Launch of our Inaugural Bio Outsourcing Asia Issue in December CanBiotech 30 Oct 2007 Bio Outsourcing Asia Medit Kit CanBiotech 13 Jun 2007 Editorial Guidelines for Bio-Outsourcing Asia CanBiotech 12 Apr 2007 Antibe Therapeutics Job Posting: Chief Development Officer Boyden Global Executive Search 10 Apr 2007 Aga Khan Foundation Canada (AKFC) Annual World Partnership Walk: Join CanBiotech to be Part of the Solution to Global Poverty CanBiotech 27 Mar 2007 |
||
| Go Back | |||
Participating on CanBiotech's Networks
Using the Site Privacy & Security
Advertise with us Directory Guide & Access Policy
News & Event Postings CanBiotech Newsletters
© 2000-2010 CanBiotech ™ Inc.